Patent intelligence · US
US 10688172
HPV particles and uses thereof
HPV particles and uses thereof
Patent details — US 10688172
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 23, 2020
- Expiration
- Jun 18, 2040
- Applicant
- Aura Biosciences, Inc.
- Claims
- 20
- CPC classes
- A61K, A61K2039/5258, A61K2039/892, A61K39/0011
Quick answer
US 10688172 (HPV particles and uses thereof) is held by Aura Biosciences, Inc.. Status: granted. Granted Jun 23, 2020. Expires Jun 18, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aura Biosciences, Inc.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K2039/5258, A61K2039/892, A61K39/0011, A61K39/12, A61K47/6901
More from Aura Biosciences, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11786503
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 11166936
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10874633
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10806716
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10596275
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 10300150
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 10179168
HPV particles and uses thereof
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 10688172?
US 10688172 (HPV particles and uses thereof) is held by Aura Biosciences, Inc.. Status: granted. Granted Jun 23, 2020. Expires Jun 18, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10688172?
Aura Biosciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 17 pharmaceutical patents for this assignee.
When does US 10688172 expire?
Our index shows an expiration date of Jun 18, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.